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OBJECTIVES The purpose was to examine the cardioprotective effects of recombinant P-selectin glyco-
protein ligand-immunoglobulin (rPSGL-Ig) in ischemia-reperfusion injury by real-time
myocardial contrast echocardiography (MCE).
BACKGROUND P-selectin mediates leukocyte recruitment into areas of inflammation.
METHODS Sixteen pigs underwent 45 min of left anterior descending coronary artery occlusion followed
by reperfusion and received rPSGL-Ig or vehicle. To assess changes in myocardial perfusion
(A  ), MCE was performed.
RESULTS After 120 min of reperfusion, A   in the risk area was higher (0.84  0.15 dB/s vs. 0.28
 0.1 dB/s, p  0.0001), and the infarct size was lower (30.3  12% vs. 57  14%, p 
0.002) in the rPSGL-Ig group compared with the vehicle group.
CONCLUSIONS Recombinant PSGL-Ig improved postischemic reflow accurately detected by real-time
MCE. (J Am Coll Cardiol 2004;44:887–91) © 2004 by the American College of
Cardiology FoundationM
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microcirculatory reflow after myocardial infarction is inti-
ately related to functional recovery (1). Leukocytes can
nduce microvascular damage in the reperfused myocar-
ium, known as “ischemia-reperfusion injury” (2,3).
-selectin glycoprotein ligand-1 (PSGL-1) is the physio-
ogic ligand for endothelial P-selectin expressed on leuko-
ytes, as well as a key molecule responsible for recruitment
f neutrophils into areas of inflammation (4,5). Recombi-
ant PSGL-Ig, a recombinant immunoglobulin form of
SGL-1, acts as a competitive inhibitor for P-selectin (6,7).
herefore, immunoneutralization of P-selectin should re-
uce the extent of leukocyte-mediated tissue damage. The
urpose of this study was to investigate whether real-time
yocardial contrast echocardiography (MCE) can be used
o evaluate microvascular reflow and the cardioprotective
ffects of rPSGL-Ig.
ETHODS
xperimental protocol. Sixteen farm pigs (20 to 25 kg)
eceived 2,500 IU heparin and 500 mg acetylsalicylic acid
nd underwent left anterior descending coronary artery
LAD) occlusion below the first branch of the LAD for 45
in, followed by 120-min reperfusion. A dose of 1 mg/kg
PSGL-Ig (6) or vehicle was given during ischemia.
From *Wyeth Research, Cambridge, Massachusetts; and Departments of †Cardi-
logy and ‡Pathology, University of Heidelberg, Heidelberg, Germany.
Manuscript received February 9, 2004; revised manuscript received April 22, 2004,dccepted May 2, 2004.yocardial contrast echocardiography. Real-time MCE
as performed serially with an HDI5000 (ATL, Bothell,
ashington) during intravenous infusion of SonoVue (60
l/h; Bracco, Milan, Italy) at a low mechanical index of
.09 and analyzed using HDI software (ATL). The risk area
as identified as the area of absent myocardial opacification
uring LAD occlusion and determined by planimetry in
nd-diastolic frames 10 cardiac cycles after flash. Perfusion
efects during reperfusion were expressed as the percentage
f risk area. The increase of signal intensities in the risk area
nd the posterolateral wall (control area) in end-systolic
rames was fitted to an exponential function: y  Ax (1 
t), as described (8). Short-axis fractional area shortening
FAS) was measured by planimetry (EchoCom, Fulda,
ermany).
istologic examinations and myocardial blood flow
MBF). The LAD was reoccluded at the end of the
xperiment, and 1 mg/kg monastral blue dye (Sigma, St.
ouis, Missouri) was injected into the left atrium to outline
he area at risk. The heart was cut into 1-cm-thick slices.
rom the myocardial slice corresponding to the MCE
maging plane transmural myocardial tissue, samples were
xcised from the central portion of the risk area, the
schemic border zone (unstained by blue dye), and the
ontrol area, divided, and processed either for analysis of
apillary density, as described (9), or measurements of
BF. The MBF was measured with 15-m fluorescent
icrospheres (Molecular Probes, Eugene, Oregon) with fiveifferent wavelengths injected into the left atrium at the
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usion), as described previously (10).
Myocardial slices were immersed in 1.3% triphenyltetra-
olium chloride (Sigma), which stains viable myocardium
ed. The infarct and risk areas in each slice were determined
y planimetry. The risk area by histology was expressed as
he percentage of the total left ventricle (LV) (equal to sum
f all slices), and the infarct size was expressed as the
ercentage of risk area.
tatistical analysis. Data are expressed as the mean value
SD, and statistical significance was set at p  0.05.
orrelations between continuous variables were performed
y linear regression analysis. The Student t test, paired or
npaired, as appropriate, was used for group-to-group
omparisons.
ESULTS
emodynamics and histologic analysis. Mean arterial
ressure and FAS decreased during reperfusion but were
igher in the rPSGL-Ig group after 120-min reperfusion
Table 1). Left ventricular weight was similar between the
PSGL-Ig and vehicle groups (66  16 g vs. 61  13 g,
able 1. Myocardial Function and Perfusion
Group Baseline Ischemia
ehicle
MAP (mm Hg) 82  10 75  9
HR (beats/min) 71  15 110  20*
FAS (%) 55  8 34  9*
MBF (ml/g/min)
Central risk area 1.29  0.4 0.03  0.01*
Ischemic border 1.23  0.3 0.04  0.01*
Control area 1.35  0.3 1.40  0.4
PSGL-Ig
MAP (mm Hg) 79  8 72  8*
HR (beats/min) 78  9 105  14*
FAS (%) 51  6 38  10*
MBF (ml/g/min)
Central risk area 1.41  0.7 0.10  0.1*
Ischemic border 1.53  0.7 0.12  0.1*
Control area 1.43  0.3 1.45  0.8
 0.05 for comparisons *between baseline and same group or †between vehicle and r
ow (MBF, microsphere-derived) was assessed in the central portion and ischemic b
SD.
Abbreviations and Acronyms
A    myocardial perfusion
FAS  fractional area shortening
LAD  left anterior descending coronary artery
LV  left ventricle
MBF  myocardial blood flow
MCE  myocardial contrast echocardiography
PSGL-1  P-selectin glycoprotein ligand-1
rPSGL-Ig  recombinant P-selectin glycoprotein
ligand-immunoglobulinFAS  fractional area shortening; HR  heart rate; MAP  mean arterial pressure. NS), as well as the risk area (% total LV) by monastral
lue staining (19.4  4% vs. 22.3  6%, p  NS). The
nfarct size to risk area by TTC staining was 57  14% and
ecreased to 30.3  12% (p  0.002) in the rPSGL-Ig
roup. Microscopic analysis demonstrated extensive myo-
ardial injury in the risk area, but the numerical capillary
ensity was higher in the rPSGL-Ig group in the central
ortion of the risk area (1,395  150 vessels/mm2 vs. 1,170
155 vessels/mm2, p 0.03) and the ischemic border zone
2,190  2,650 vessels/mm2 vs. 1,435  10 vessels/mm2, p
0.01), but similar in the nonischemic area (3,270 6,100
essels/mm2 vs. 3,590  830 vessels/mm2, p  NS).
etermination of reflow by real-time MCE. Real-time
CE allowed direct visualization of the risk area during
AD occlusion and postischemic reflow (Fig. 1). The risk
rea by MCE was similar in both groups (42 6% vs. 38
%, p  NS). Similar to histologic findings, rPSGL-Ig
educed the perfusion defect size to risk area by 49%, from
8  10% to 35  9% (p  0.001) (Fig. 2). Postischemic
now-reflow” zones correlated well with the infarct size by
TC staining of the corresponding myocardial slice
Fig. 2).
After initial hyperemia, a progressive reduction in myo-
ardial perfusion was observed during reperfusion, which
ould be correctly quantified by MCE. A, , and A  
radually decreased during reperfusion but were higher in
he rPSGL-Ig group, indicating preserved MBF in the risk
rea (Fig. 3). Recombinant PSGL-Ig reduced the decrease
f A by 61% (59  15% vs. 23  14%, p  0.003) and A
 by 49% (67  13% vs. 34  15%, p  0.008), but not
(relative reduction of 12%, from 47  8% to 40  9%, p
NS). Myocardial blood flow by microspheres confirmed
he cardioprotective effects of rPSGL-Ig on microvascular
ow (Table 1). A   correlated with MBF (r  0.66, p 
Reperfusion (min)
5 30 60 120
 11 78  9 74  6 70  7*
 9* 115  11* 108  9* 100  18*
 7 48  9 41  7* 32  6*
 1.2 — 1.32  0.9 0.85  0.4*
 1.3 — 1.72  0.8 1.20  0.3
 0.2 — 1.39  0.4* 1.21  0.4
 10 77  11 84  8 81  9†
 10* 100  12 102  15 95  13
 7 50  10 49  7 44  8†
 1.2* — 2.45  0.8† 1.65  0.5†
 1.4* — 2.66  0.7 1.86  0.4†
 0.5 — 1.56  0.6 1.38  0.5
inant P-selectin glycoprotein ligand–immunoglobulin (rPSGL-Ig). Myocardial blood
of the risk area and nonischemic control area. Data are presented as the mean value80
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August 18, 2004:887–91 Cardioprotective Effects of rPSGL-Ig.001), and A correlated with capillary density (r 0.8, p
.007).
Repeated measurements of A   showed a good
eproducibility (r 0.93, p 0.0001), with a mean 2 SD
f 0.013  0.38 dB/s. The risk area was not significantly
ifferent when assessed 3 or 10 heart cycles after flash,
hich demonstrates low collateral flow in pigs.
ISCUSSION
he present study outlines the pathophysiologic implication
f P-selectin in the development of ischemia-reperfusion
njury. Immunoneutralization of P-selectin by rPSGL-Ig
educed the infarct size and preserved microvascular integ-
ity accurately detected by real-time MCE.
ssessment of ischemia-reperfusion injury by MCE.
riggered MCE techniques have been used extensively in
cute coronary syndromes and shifted the interest from
nfarct-related artery patency to microvascular integrity
1–3,8). However, practical considerations have limited its
roader clinical use. Real-time MCE allows simultaneous
valuation of myocardial perfusion and contractility and
igure 1. Real-time myocardial contrast echocardiography with reappea
yocardial infarction after 120-min reperfusion, with complete loss of c
eperfusion after temporary ischemia with contrast enhancement appears fibviates the need for background subtraction, but little Tnformation is available on the detection of postischemic
icrovascular dysfunction. In this study, myocardial perfu-
ion could be easily visualized and quantified by real-time
CE. Furthermore, MCE confirmed a fully reperfused risk
rea characterized by absent perfusion defects and hyper-
mic reflow. During follow-up, the MBF index A  
ecreased with reappearance of a marked perfusion defect.
he infarct size and MBF by MCE corresponded well with
tandard techniques. These findings are in agreement with
revious reports based on triggered and real-time techniques
11,12).
Kunichika et al. (12) recently demonstrated the usefulness
f real-time MCE to assess the cardioprotective effects of
lycoprotein IIb/IIIa inhibition in a canine model of 3-h
schemia. In contrast to our model, no significant changes in
erfusion during reperfusion were reported, most likely
eflecting extensive irreversible injured myocardium occur-
ing during ischemia, as well as the inability to reperfuse the
yocardium. The duration of ischemia was shorter in our
tudy (45 min), resulting initially in hyperemic reflow with
gradual decrease in myocardial perfusion patterns A and .
of myocardial contrast after bubble destruction (“flash”). Transmural
t enhancement in the risk area (a to c). Hyperemic reflow during early
the left anterior descending coronary artery perfusion territory (d to f).rance
ontras
rst inhis supports the existence of ischemia-reperfusion injury
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Cardioprotective Effects of rPSGL-Ig August 18, 2004:887–91haracterized by serial changes in the postischemic micro-
irculation.
ardioprotective effects of rPSGL-Ig. In the present
tudy, we used rPSGL-Ig, a recombinant immunoglobulin
orm of PSGL-1, which has been mutated to reduce both
omplement activation and Fc receptor binding with a
alf-life of 11 days in pigs (4–6). As a result, P-selectin
lockade by rPSGL-Ig administrated at the time of reper-
usion, on top of standard therapy with heparin and acetyl-
alicylic acid, reduced myocardial ischemia-reperfusion in-
ury. This was manifested by a marked reduction in infarct
ize of 50%, improved myocardial capillary density, and
lood flow, in agreement with previous studies (7).
igure 2. Time course in the perfusion defect size to risk area by
yocardial contrast echocardiography (MCE) (top). *p  0.05 for com-
arisons between vehicle (solid lines) and recombinant P-selectin glyco-
rotein ligand-immunoglobulin (rPSGL-Ig) (dashed lines). Correlation
etween the perfusion defect size to risk area by MCE at 120-min
eperfusion and the infarct size to risk area of the corresponding myocardial
lice by TTC staining (bottom) in the rPSGL-Ig (circles) and vehicle
squares) groups.PSGL-1 binds to P-selectin and is a key molecule mesponsible for recruitment of neutrophils into areas of
nflammation and adhesion of platelets to neutrophils.
herefore, a proposed mechanism of rPSGL-Ig is the
reservation of endothelial function through inhibition of
eukocyte adhesion, thus potentially maintaining nitric ox-
de release and vasodilation (2,6,13). Although we did not
irectly investigate the pathophysiologic implications of
eukocytes, we could observe that plateau A, an index of
apillary volume, was elevated for a prolonged time after
eperfusion in the rPSGL-Ig group. Hence, failure to
espond to hyperemia after ischemia may be an ominous
ign of a dysfunctional and damaged microvasculature,
riggering a lethal reperfusion injury. Besides, P-selectin
igure 3. Quantitative myocardial contrast echocardiography parameters A
top),  (middle), and A   (bottom) in the left anterior descending
oronary artery (LAD) territories at baseline (bas), during LAD occlusion
occ), and reperfusion. The decrease in indexes of myocardial perfusion
uring reperfusion was lower in the recombinant P-selectin glycoprotein
igand-immunoglobulin (rPSGL-Ig) group (dashed lines) than in the
ehicle group (solid lines). *p  0.05.ediates interactions between platelets and neutrophils,
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August 18, 2004:887–91 Cardioprotective Effects of rPSGL-Ighich has potential implications, as leukocyte-platelet ag-
regates contribute to microvascular obstruction. Indeed,
-selectin blockade reduced platelet deposition on injured
rterial surfaces (13) and enhanced thrombolysis (6) without
n increase in bleeding rate.
linical implications. Our study provides strong evidence
f the detrimental effects of postischemic reperfusion and
uggests a potential role of P-selectin in the pathogenesis of
schemia-reperfusion injury. However, it is not easy to
peculate whether rPSGL-Ig may provide a beneficial ad-
unct to standard reperfusions strategies. The selectin an-
agonist CY-1503 reduced the extent of reperfusion lung
njury (14), but rPSGL-Ig, currently studied in phase I/II
linical trials, failed to improve thrombolysis in patients
ith myocardial infarction (15). However, soluble
-selectin and intercellular adhesion molecule-1 concentra-
ions were consistently elevated after percutaneous translu-
inal coronary angioplasty but not after thrombolysis with
issue-type plasminogen activator (16). Additional studies
re needed to further elucidate this clearly exciting approach
o preserve microvascular integrity. Because real-time MCE
as been improved both qualitatively and quantitatively, it
ay become invaluable in the diagnosis and management of
cute ischemic syndromes.
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